Adiponectin inhibits the progression of various metabolic and cardiovascular diseases by promoting the transition of macrophages from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype (Ohashi et al., 2010). This evidence concerns the gene ADIPOQ and cardiovascular disorder.